Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.

MLA

Gupta, Amita, et al. “Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 3, Mar. 2024, pp. 667–73. EBSCOhost, https://doi.org/10.1093/cid/ciad583.

APA

Gupta, A., Hughes, M. D., Cruz, J. L., Avihingsanon, A., Mwelase, N., Severe, P., Omoz-Oarhe, A., Masheto, G., Moran, L., Benson, C. A., Chaisson, R. E., & Swindells, S. (2024). Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 78(3), 667–673. https://doi.org/10.1093/cid/ciad583

Chicago

Gupta, Amita, Michael D Hughes, Jorge Leon Cruz, Anchalee Avihingsanon, Noluthando Mwelase, Patrice Severe, Ayotunde Omoz-Oarhe, et al. 2024. “Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78 (3): 667–73. doi:10.1093/cid/ciad583.